Patient Characteristics, Microbiology, and Mortality of Infective Endocarditis After Transcatheter Aortic Valve Implantation
Clinical Infectious Diseases · 15.12.2023 · 77 (12) · 1617-1625
DOI: 10.1093/cid/ciad431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.07.2023. Verfasst von Jarl Emanuel Strange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Prosthesis-Related Infections, Endocarditis, Bacterial, Endocarditis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is associated with high mortality and surgery is rarely performed. Thus, to inform on preventive measures and treatment strategies, we investigated patient characteristics and microbiology of IE after TAVI.
Methods
Using Danish nationwide registries, we identified patients with IE after TAVI, IE after non-TAVI prosthetic valve (nTPV), and native valve IE. Patient characteristics; overall, early (≤12 m), and late IE (>12 m) microbiology; and unadjusted and adjusted mortality were compared.
Results
We identified 273, 1022, and 5376 cases of IE after TAVI, IE after nTPV, and native valve IE. Age and frailty were highest among TAVI IE (4.8%; median age: 82 y; 61.9% frail). Enterococcus spp. were common for IE after TAVI (27.1%) and IE after nTPV (21.2%) compared with native valve IE (11.4%). Blood culture–negative IE was rare in IE after TAVI (5.5%) compared with IE after nTPV (15.2%) and native valve IE (13.5%). The unadjusted 90-day mortality was comparable, but the 5-year mortality was highest for IE after TAVI (75.2% vs 57.2% vs 53.6%). In Cox models adjusted for patient characteristics and bacterial etiology for 1–90 days and 91–365 days, there was no significant difference in mortality rates.
Conclusions
Patients with IE after TAVI are older and frailer, enterococci and streptococci are often the etiologic agents, and are rarely blood culture negative compared with other IE patients. Future studies regarding antibiotic prophylaxis strategies covering enterococci should be considered in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
- Statens Serum Institut, Copenhagen, Denmark.
- The Danish Heart Foundation, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Jarl Emanuel Strange
Zitieren
APA
Strange, J. E., Østergaard, L., Køber, L., Bundgaard, H., Iversen, K., Voldstedlund, M., Gislason, G. H., Olesen, J. B., & Fosbøl, E. L. (2023). Patient Characteristics, Microbiology, and Mortality of Infective Endocarditis After Transcatheter Aortic Valve Implantation. Clinical Infectious Diseases, 77(12), 1617-1625. https://doi.org/10.1093/cid/ciad431
Vancouver
Strange JE, Østergaard L, Køber L, Bundgaard H, Iversen K, Voldstedlund M, et al. Patient Characteristics, Microbiology, and Mortality of Infective Endocarditis After Transcatheter Aortic Valve Implantation. Clinical Infectious Diseases. 2023;77(12):1617-1625. doi:10.1093/cid/ciad431
BibTeX
@article{Strange2023,
author = {Strange, Jarl Emanuel and Østergaard, Lauge and Køber, Lars and Bundgaard, Henning and Iversen, Kasper and Voldstedlund, Marianne and Gislason, Gunnar Hilmar and Olesen, Jonas Bjerring and Fosbøl, Emil Loldrup},
title = {Patient Characteristics, Microbiology, and Mortality of Infective Endocarditis After Transcatheter Aortic Valve Implantation},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {12},
pages = {1617--1625},
doi = {10.1093/cid/ciad431}
}
EUVIMED